banner
ROCK inhibitor RKI-1313, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ808

ROCK inhibitor RKI-1313, Purity ≥98%

Synonym: 1342276-76-9; RKI-1313; 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea; 1-[(3-Methoxyphenyl)methyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea; RKI 1313; 1-[(3-Methoxyphenyl)methyl]-3-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]urea; ROCK inhibitor

  • MDL: MFCD27996044
  • CAS Number: 1342276-76-9
  • Compound CID: 53492330
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
RKI-1313 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity.
Molecular Weight
340.401
Molecular Formula
C17H16N4O2S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
RKI-1313 can be used to study its inhibitory effects on Rho kinase and its potential therapeutic benefits in cardiovascular diseases.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0